Corvus Pharmaceuticals, Inc. ( CRVS) - Stock Earnings
CRVS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -12.3 million USD | — USD |
| 2026Q1 | -13.7 million USD | — USD |
| 2026Q2 | -18.0 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
CRVS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -27.0 million USD | — USD |
| 2024 | -62.3 million USD | — USD |
| 2025 | -15.3 million USD | — USD |
| 2026 Est. | — | — |
CRVS
Price: $14.89
52 week price:
Earnings Per Share: -0.64 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 47000
Ebitda: -12.7 millionMarket Capitalization: 1.2 billion